Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Asia, Europe, and North America. The aim of this clinical
trial is to compare the efficacy and safety of NN1250 (insulin degludec (IDeg)) with insulin
glargine (IGlar) in subjects with type 2 diabetes currently treated with metformin alone or
with metformin combined with an oral anti-diabetic drug (OAD) qualifying for intensified
treatment.